MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
LTRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lantern Pharma (LTRN) Ownership - Who owns Lantern Pharma?

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
16
Web
https://www.lanternpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
49.25M
P/E Ratio
N/A
Total Cash
6.32M
Projected Growth
N/A
Total Debt
59.08K
Revenue
N/A
Risk (Beta)
4.88
Dividend Yield
N/A
Total Cash/Share
0.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
LTRN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for LTRN
A.I. Advisor
published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
16
Web
https://www.lanternpharma.com